Responsible use of vaccines and vaccination in fish production
... medications in the commercial farming situation are administered either in-feed or by immersion. In the case of administration of medicinal products such as antibiotics the injection route is reserved for small numbers of individual high value subjects such as broodstock. Bathing or immersion of fis ...
... medications in the commercial farming situation are administered either in-feed or by immersion. In the case of administration of medicinal products such as antibiotics the injection route is reserved for small numbers of individual high value subjects such as broodstock. Bathing or immersion of fis ...
Pneumococcal and Influenza vaccine
... (including but not limited to asthma, cardiac disease, sickle cell disease, human immunodeficiency virus [HIV] and diabetes) handwashing, especially when exposed to individuals with ...
... (including but not limited to asthma, cardiac disease, sickle cell disease, human immunodeficiency virus [HIV] and diabetes) handwashing, especially when exposed to individuals with ...
Hepatitis B Prevention
... Hepatitis B Vaccination Targets 45th World Health Assembly, 1992 Integrate hepatitis B vaccine into national childhood vaccination programs •By 1995 in countries with HBsAg prevalence 8% •By 1997 in all countries ...
... Hepatitis B Vaccination Targets 45th World Health Assembly, 1992 Integrate hepatitis B vaccine into national childhood vaccination programs •By 1995 in countries with HBsAg prevalence 8% •By 1997 in all countries ...
www.proactiveinvestors.com
... development programs, evaluation of potential opportunities, the level of corporate expenditures, the assessment of Inovio’s technology by potential corporate partners, capital market conditions, timing of events, cash consumption and other subjects. Information concerning factors that could cause a ...
... development programs, evaluation of potential opportunities, the level of corporate expenditures, the assessment of Inovio’s technology by potential corporate partners, capital market conditions, timing of events, cash consumption and other subjects. Information concerning factors that could cause a ...
S. mansoni - York College of Pennsylvania
... Bacille Calmette-Guérin (BCG) Vaccine Against Pulmonary Tuberculosis Sadie Forrester Department of Biological Sciences, York College of Pennsylvania ...
... Bacille Calmette-Guérin (BCG) Vaccine Against Pulmonary Tuberculosis Sadie Forrester Department of Biological Sciences, York College of Pennsylvania ...
Infectious Laryngotracheitis
... When a caseous plug occludes the larynx or trachea, the affected chickens will have extreme difficulty breathing ("pump handle" breathing) and will frequently die from suffocation. Mortality is approximately 1 % per day in a typical ILT outbreak. Milder forms of ILT outbreaks occur where less virule ...
... When a caseous plug occludes the larynx or trachea, the affected chickens will have extreme difficulty breathing ("pump handle" breathing) and will frequently die from suffocation. Mortality is approximately 1 % per day in a typical ILT outbreak. Milder forms of ILT outbreaks occur where less virule ...
Immunological Basis of Vaccination
... We will focus on the antibody response to this pathogen, as this is probably a critical component of protective immunity to influenza. Until recently only killed vaccines were commercially available for equine influenza, but in young horses in particular they gave short-lasting protection at best.5 ...
... We will focus on the antibody response to this pathogen, as this is probably a critical component of protective immunity to influenza. Until recently only killed vaccines were commercially available for equine influenza, but in young horses in particular they gave short-lasting protection at best.5 ...
Development of Vaccine and Diagnostics for Prevention and Control
... Economic aspects of vaccine relates with cost analysis, cost-benefit analysis, cost effectiveness analysis, and cost-utility analysis. Immunization is an excellent investment which is highly cost-effective and usually cost-saving for vaccines that are currently recommended for global use. Even thoug ...
... Economic aspects of vaccine relates with cost analysis, cost-benefit analysis, cost effectiveness analysis, and cost-utility analysis. Immunization is an excellent investment which is highly cost-effective and usually cost-saving for vaccines that are currently recommended for global use. Even thoug ...
Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated
... Merck and Co., Inc.) as one of three HPV vaccines that can be used for routine vaccination (Table 1). HPV vaccine is recommended for routine vaccination at age 11 or 12 years (1). ACIP also recommends vaccination for females aged 13 through 26 years and males aged 13 through 21 years not vaccinated ...
... Merck and Co., Inc.) as one of three HPV vaccines that can be used for routine vaccination (Table 1). HPV vaccine is recommended for routine vaccination at age 11 or 12 years (1). ACIP also recommends vaccination for females aged 13 through 26 years and males aged 13 through 21 years not vaccinated ...
PRESS RELEASE - Themis Bioscience GmbH
... placebo treatment. One treatment group will receive one injection of high dose vaccine, the other two groups will receive two shots of either high dose or low dose vaccine. Safety will be measured according to the occurrence of adverse events and side effects of the study medication. Efficacy will ...
... placebo treatment. One treatment group will receive one injection of high dose vaccine, the other two groups will receive two shots of either high dose or low dose vaccine. Safety will be measured according to the occurrence of adverse events and side effects of the study medication. Efficacy will ...
Update on herpes zoster vaccination
... HZ are often the most insistent on receiving the vaccine,17 and concerns have been raised about the validity of patient histories of HZ. For these reasons, both the Centers for Disease Control and Prevention and the ACIP recommend that adults be vaccinated whether or not they report a previous episo ...
... HZ are often the most insistent on receiving the vaccine,17 and concerns have been raised about the validity of patient histories of HZ. For these reasons, both the Centers for Disease Control and Prevention and the ACIP recommend that adults be vaccinated whether or not they report a previous episo ...
Children from Birth through 6 Years Old
... T wo doses of HepA vaccine are needed for lasting protection. The first dose of HepA vaccine should be given between 12 months and 23 months of age. The second dose should be given 6 to 18 months later. HepA vaccination may be given to any child 12 months and older to protect against HepA. Childr ...
... T wo doses of HepA vaccine are needed for lasting protection. The first dose of HepA vaccine should be given between 12 months and 23 months of age. The second dose should be given 6 to 18 months later. HepA vaccination may be given to any child 12 months and older to protect against HepA. Childr ...
It`s always fatal. Is your Dog protecteD? Don`t let your pet become a
... rabies vaccine. Veterinarians have trusted iMrab rabies vaccine to protect millions of animals — six species in all, including dogs, cats and ferrets — for 20 years. In fact, it’s the leading vaccine for rabies protection worldwide.4 ...
... rabies vaccine. Veterinarians have trusted iMrab rabies vaccine to protect millions of animals — six species in all, including dogs, cats and ferrets — for 20 years. In fact, it’s the leading vaccine for rabies protection worldwide.4 ...
Common questions about the flu vaccination
... The risk of serious illness from flu and consequent hospitalisation and death is higher among those aged 65 years and older as they are more likely to have an underlying health problem and the immune system does not work as well. The best way for people at risk from flu to protect themselves is to g ...
... The risk of serious illness from flu and consequent hospitalisation and death is higher among those aged 65 years and older as they are more likely to have an underlying health problem and the immune system does not work as well. The best way for people at risk from flu to protect themselves is to g ...
BOVINE PRODUCT GUIDE VACCINES Modified Live Vaccines
... For more information, please contact your Boehringer Ingelheim (Canada) Ltd. Territory Manager or call Customer Care at 1-800-567-1885. For technical support on any of our products, please call 1-877-565-5501. Reference: 1. Bryant TC, Rodgers KC, Stone ND, Miles DG. 2008. Effect of viral respiratory ...
... For more information, please contact your Boehringer Ingelheim (Canada) Ltd. Territory Manager or call Customer Care at 1-800-567-1885. For technical support on any of our products, please call 1-877-565-5501. Reference: 1. Bryant TC, Rodgers KC, Stone ND, Miles DG. 2008. Effect of viral respiratory ...
dna vaccine technology - Immunomic Therapeutics, Inc.
... Because of the unique design features of the LAMP platform, these vaccines are designed to activate both the acquired or adaptive immunity mediated by CD4+ T-cells and the cellular immunity mediated by CD8+ T-cells – both arms of the immune system. LAMP provides an elegantly designed solution to dir ...
... Because of the unique design features of the LAMP platform, these vaccines are designed to activate both the acquired or adaptive immunity mediated by CD4+ T-cells and the cellular immunity mediated by CD8+ T-cells – both arms of the immune system. LAMP provides an elegantly designed solution to dir ...
Herpes Zoster Vaccination
... Herpes Zoster Vaccination Why vaccinate? - 1 million cases/ year in the US - $ 1 billion/ year spent on treating HZV - Pain and suffering (rx not always effective/ available, 72 h window) - Prevention of complications ...
... Herpes Zoster Vaccination Why vaccinate? - 1 million cases/ year in the US - $ 1 billion/ year spent on treating HZV - Pain and suffering (rx not always effective/ available, 72 h window) - Prevention of complications ...
(AEFI)?
... A medical incident that takes place after an immunization, causes concern, and is believed to be caused by immunization ...
... A medical incident that takes place after an immunization, causes concern, and is believed to be caused by immunization ...
Nikki Mills Paediatric ENT Consultant Starship Hospital
... Natural history of acute otitis media • Most acute otitis media are bacterial infection involving big 3 Natural history @ 1-2 days 60% of kids w AOM improved @ 3-7days 75% acute symptoms resolve • Resolution of middle ear fluid longer but mostly gone by 6wks (5-10% persist @ 2mths) • Antibiotics mo ...
... Natural history of acute otitis media • Most acute otitis media are bacterial infection involving big 3 Natural history @ 1-2 days 60% of kids w AOM improved @ 3-7days 75% acute symptoms resolve • Resolution of middle ear fluid longer but mostly gone by 6wks (5-10% persist @ 2mths) • Antibiotics mo ...
Journal of Pediatric Infection
... We present you the first issue of the year 2015 of the Journal of Pediatric Infection (Çocuk Enfeksiyon Dergisi), the official publication organ of the Society of Pediatric Infectious Diseases. In this issue, we present an editorial consensus proposal on the National Vaccination Schedule, which was ...
... We present you the first issue of the year 2015 of the Journal of Pediatric Infection (Çocuk Enfeksiyon Dergisi), the official publication organ of the Society of Pediatric Infectious Diseases. In this issue, we present an editorial consensus proposal on the National Vaccination Schedule, which was ...
GVMA Paper – June 2004 Meeting
... immunosuppressed individuals are incapable of mounting a significant inflammatory and immune response against the vaccine organism, and they may suffer significant consequences of the vaccine “infection”. Some types of agents, such as herpesviruses, are also prone to development of latent infections ...
... immunosuppressed individuals are incapable of mounting a significant inflammatory and immune response against the vaccine organism, and they may suffer significant consequences of the vaccine “infection”. Some types of agents, such as herpesviruses, are also prone to development of latent infections ...
November-December 1999: Volume 27, Number 6 (PDF: 43KB/4 pages)
... first dose of HBV vaccine within 1 day of birth. Ninety-five percent of infants received the second dose of vaccine by 4 months of age, and 74% completed the three-dose vaccine series by 8 months of age. Follow-up serologic testing for hepatitis B surface antibody (anti-HBs) has been completed for 1 ...
... first dose of HBV vaccine within 1 day of birth. Ninety-five percent of infants received the second dose of vaccine by 4 months of age, and 74% completed the three-dose vaccine series by 8 months of age. Follow-up serologic testing for hepatitis B surface antibody (anti-HBs) has been completed for 1 ...
Frequently Asked Questions about HPV and the Vaccine What are
... Currently there is no ACIP recommendation for an individual fully vaccinated with quadrivalent HPV vaccine to receive the 9-valent HPV vaccine series. 7. Does a girl who receives the Quadivalent vaccine, does she need to be updated with the 9-valent vaccine for better vaccination coverage? Curre ...
... Currently there is no ACIP recommendation for an individual fully vaccinated with quadrivalent HPV vaccine to receive the 9-valent HPV vaccine series. 7. Does a girl who receives the Quadivalent vaccine, does she need to be updated with the 9-valent vaccine for better vaccination coverage? Curre ...